摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Agn-PC-0LP1QD | 7227-22-7

中文名称
——
中文别名
——
英文名称
Agn-PC-0LP1QD
英文别名
5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,49-tridecol
Agn-PC-0LP1QD化学式
CAS
7227-22-7
化学式
C42H70O34
mdl
——
分子量
1119.0
InChiKey
ADMHCAPIDLNHJS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -14
  • 重原子数:
    76
  • 可旋转键数:
    7
  • 环数:
    21.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    534
  • 氢给体数:
    20
  • 氢受体数:
    34

文献信息

  • MICROSPHERES CONTAINING THERAPEUTIC AGENTS AND RELATED METHODS OF USE
    申请人:Biosphere Medical, Inc.
    公开号:US20170231915A1
    公开(公告)日:2017-08-17
    Microspheres, compositions including the microspheres, and methods of using the microspheres are disclosed herein. The microspheres can be substantially spherical and can include a copolymer of a monomer (such as an acrylic monomer) and a cyclodextrin or a derivative thereof. The microspheres can also include a therapeutic agent, such as a platinum-based drug.
    本文公开了微球、包括微球的组合物以及使用微球的方法。这些微球可以是基本球形的,可以包括单体的共聚物(如丙烯酸单体)和环糊精或其衍生物。这些微球还可以包括治疗剂,如基于铂的药物。
  • CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY
    申请人:Davis Mark E.
    公开号:US20110282047A1
    公开(公告)日:2011-11-17
    Described herein is a cyclodextrin containing polymer conjugate.
    这里描述了一种含有环糊精的聚合物共轭物。
  • CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
    申请人:Crawford Thomas C.
    公开号:US20120058971A1
    公开(公告)日:2012-03-08
    Methods and compositions relating to CDP-taxane conjugates are described herein.
    本文描述了与CDP-紫杉醇结合物有关的方法和组合物。
  • TREATMENT OF CANCER
    申请人:Ryan John
    公开号:US20160058875A1
    公开(公告)日:2016-03-03
    Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
    提供了涉及包含CDP-拓扑异构酶抑制剂的组合物的方法,例如CDP-喜树碱或喜树碱衍生物结合物,例如CRLX101。
  • PROCESS FOR HYDROCRACKING A HYDROCARBON FEED IN THE PRESENCE OF A SULPHIDE CATALYST PREPARED USING A CYCLIC OLIGOSACCHARIDE
    申请人:Diehl Fabrice
    公开号:US20130140215A1
    公开(公告)日:2013-06-06
    Hydrocracking a hydrocarbon feed in the presence of a catalyst comprising an acidic support and an active phase formed from at least one metal from group VIII and at least one metal from group VIB, said catalyst being prepared using a process comprising, in succession: contacting a pre-catalyst comprising said metal from group VIII, said metal from group VIB and said acidic support with a cyclic oligosaccharide of at least 6α-(1,4)-bonded glucopyranose subunits; contacting the acidic support with a solution containing a precursor of metal from group VIII, a precursor of said metal from group VIB and a cyclic oligosaccharide of at least 6α-(1,4)-bonded glucopyranose subunits; and contacting acidic support with a cyclic oligosaccharide of at least 6α-(1,4)-bonded glucopyranose subunits followed by a second contacting acidic solid with a precursor of metal from group VIII and a precursor of metal from group VIB; drying; heat treatment; sulphurization.
查看更多